04:23 AM EDT, 10/01/2024 (MT Newswires) -- Moderna ( MRNA ) and Cenra Healthcare said late Monday that they have agreed on a deal for the co-promotion of Moderna's ( MRNA ) mRNA respiratory vaccines in Taiwan.

Financial terms were not disclosed.

Under the agreement, Moderna ( MRNA ) will manufacture and distribute its respiratory vaccines, including its Spikevax COVID-19 vaccine, while Cenra will promote the jabs across Taiwan.

The deal will initially extend until 2027.

Price: 66.96, Change: +0.13, Percent Change: +0.20